MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma (Q41962843)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 December 2009
edit
Language Label Description Also known as
English
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
scientific article published on 14 December 2009

    Statements

    MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma (English)
    1 reference
    Andreana L Rivera
    1 reference
    Christopher E Pelloski
    1 reference
    Mark R Gilbert
    1 reference
    Howard Colman
    1 reference
    Clarissa De La Cruz
    1 reference
    Erik P Sulman
    1 reference
    B Nebiyou Bekele
    1 reference
    Kenneth D Aldape
    1 reference
    14 December 2009
    1 reference
    12
    1 reference
    116-121
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit